• Weight loss
  • Weight loss

Amycretin: Novo Nordisk is developing innovative weight loss pill

Written by: Editors

Modified on: 

With obesity levels soaring worldwide, a lot of people are searching for effective solutions that can help them to lose weight. Novo Nordisk, known for developing the weight loss drugs Ozempic and Wegovy, has announced the development of a new weight loss drug called Amycretin. Amycretin is currently being tested in early trials, and while it's still too early to draw definitive conclusions, the initial results have been promising and well received by those seeking effective weight loss solutions.

Obesity epidemic

Obesity is a growing health concern in many countries around the world with serious implications for the health of the general population. A variety of factors, such as genetics, lifestyle and metabolic processes, can hinder weight loss. Medical science continues to look for innovative solutions to this problem. 

Amycretin: a new approach to weight loss

Developed by Novo Nordisk, Amycretin distinguishes itself by targeting two biological mechanisms involved in appetite regulation and metabolism, offering a novel approach to curb hunger. With its dual-action mechanism, Amycretin is positioned as a potentially superior option compared to traditional weight loss solutions. 

How does Amycretin work?

Amycretin not only targets the glucagon-like peptide 1 hormone (GLP-1), which plays a crucial role in regulating appetite and stimulating satiety, it also affects the amylin hormone, which reduces hunger and delays stomach emptying. In phase 1 trials, Amycretin was found to significantly reduce body weight by 13% over a 12week period, a noteworthy improvement compared to the 6% reduction seen with Wegovy over the same period. 

Access to Amycretin

Amycretin is still in the early stages of development, so further clinical trials will be needed to confirm its efficacy and safety before it can be marketed. However, Novo Nordisk anticipates the weight loss pill could be available to consumers by the end of this decade. 


Amycretin is a promising new weight loss drug and a potential game-changer in weight management. New developments in medical science and ongoing trails for Amycretin indicate a hopeful future for individuals worldwide seeking effective weight loss solutions. 

Want to know more about obesity?  

All treatments
Back to top